Legend Biotech (LEGN) Common Equity (2019 - 2025)
Historic Common Equity for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $37000.0.
- Legend Biotech's Common Equity changed 0.0% to $37000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $37000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $37000.0 for FY2024, which is 277.78% up from last year.
- As of Q3 2025, Legend Biotech's Common Equity stood at $37000.0, which was down 0.0% from $37000.0 recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Common Equity registered a high of $744.3 million during Q4 2022, and its lowest value of $27.0 during Q1 2021.
- Moreover, its 5-year median value for Common Equity was $36000.0 (2023), whereas its average is $43.8 million.
- As far as peak fluctuations go, Legend Biotech's Common Equity skyrocketed by 240090645.16% in 2022, and later crashed by 9999.52% in 2023.
- Quarter analysis of 5 years shows Legend Biotech's Common Equity stood at $31000.0 in 2021, then surged by 2400906.45% to $744.3 million in 2022, then plummeted by 100.0% to $36000.0 in 2023, then increased by 2.78% to $37000.0 in 2024, then changed by 0.0% to $37000.0 in 2025.
- Its Common Equity was $37000.0 in Q3 2025, compared to $37000.0 in Q2 2025 and $37000.0 in Q1 2025.